Pneumonitis during interferon and/or herbal drug therapy in patients with chronic active hepatitis

被引:70
作者
Ishizaki, T
Sasaki, F
Ameshima, S
Shiozaki, K
Takahashi, H
Abe, Y
Ito, S
Kuriyama, M
Nakai, T
Kitagawa, M
机构
[1] FUKUI MED SCH,DEPT INTERNAL MED 2,MATSUOKA,FUKUI 91011,JAPAN
[2] TOYAMA MED & PHARMACEUT UNIV,DEPT PATHOL 1,TOYAMA,JAPAN
[3] FUKUI MED SCH,DEPT INTERNAL MED 3,MATSUOKA,FUKUI 91011,JAPAN
关键词
chronic active hepatitis; herb drug; interferon; pneumonitis; soluble interleukin-2 receptor;
D O I
10.1183/09031936.96.09122691
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
We report four cases of acute pneumonitis due either to interferon, or a herbal drug, ''Sho-saiko-to'', or both in combination, in patients with chronic active hepatitis, focusing on its pathogenesis and response to prednisolone therapy. These cases shared common clinical features: fever, dry cough, dyspnoea, hyperaemia, diffuse infiltrates both on chest radiography and chest computed tomography, restrictive pulmonary functional impairment, and alveolitis on examination of transbronchial lung biopsy, all of which suggest acute interstitial pneumonia, Furthermore, lymphocytosis was observed in association with the dominant CD8+ T-cell subset in bronchoalveolar lavage fluid, A lymphocyte stimulation test using peripheral blood was positive to interferon in one case and to Sho-saiko-to in another, All patients responded to oral prednisolone therapy, Peripheral soluble interleukin-2 receptor levels decreased in parallel with improvement in the clinical course, All patients were free of symptoms with a follow-up of 1-3 yrs. We conclude that interferon- and/or Sho-saiko-to-induced acute pneumonitis may be due to allergic-immunological mechanisms rather than toxicity, and that peripheral Levels of soluble interleukin-2 receptor appear to be good markers of disease activity.
引用
收藏
页码:2691 / 2696
页数:6
相关论文
共 32 条
[1]   ACUTE EOSINOPHILIC PNEUMONIA AS A REVERSIBLE CAUSE OF NONINFECTIOUS RESPIRATORY-FAILURE [J].
ALLEN, JN ;
PACHT, ER ;
GADEK, JE ;
DAVIS, WB .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (09) :569-574
[2]   JAPANESE SUMMER-TYPE HYPERSENSITIVITY PNEUMONITIS - GEOGRAPHIC-DISTRIBUTION, HOME-ENVIRONMENT, AND CLINICAL CHARACTERISTICS OF 621 CASES [J].
ANDO, M ;
ARIMA, K ;
YONEDA, R ;
TAMURA, M .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1991, 144 (04) :765-769
[3]   ACUTE INTERSTITIAL NEPHRITIS WITH THE NEPHROTIC SYNDROME FOLLOWING RECOMBINANT LEUKOCYTE-A INTERFERON THERAPY FOR MYCOSIS-FUNGOIDES [J].
AVERBUCH, SD ;
AUSTIN, HA ;
SHERWIN, SA ;
ANTONOVYCH, T ;
BUNN, PA ;
LONGO, DL .
NEW ENGLAND JOURNAL OF MEDICINE, 1984, 310 (01) :32-35
[4]   PNEUMONITIS ASSOCIATED WITH NATURAL AND RECOMBINANT INTERFERON-ALFA THERAPY FOR CHRONIC HEPATITIS-C [J].
CHIN, KZ ;
TABATA, C ;
SATAKE, N ;
NAGAI, S ;
MORIYASU, F ;
KUNO, K .
CHEST, 1994, 105 (03) :939-941
[5]   PULMONARY-EDEMA AS A COMPLICATION OF INTERLEUKIN-2 THERAPY [J].
CONANT, EF ;
FOX, KR ;
MILLER, WT .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1989, 152 (04) :749-752
[6]   TREATMENT OF CHRONIC HEPATITIS-C WITH RECOMBINANT INTERFERON-ALFA - A MULTICENTER RANDOMIZED, CONTROLLED TRIAL [J].
DAVIS, GL ;
BALART, LA ;
SCHIFF, ER ;
LINDSAY, K ;
BODENHEIMER, HC ;
PERRILLO, RP ;
CAREY, W ;
JACOBSON, IM ;
PAYNE, J ;
DIENSTAG, JL ;
VANTHIEL, DH ;
TAMBURRO, C ;
LEFKOWITCH, J ;
ALBRECHT, J ;
MESCHIEVITZ, C ;
ORTEGO, TJ ;
GIBAS, A .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (22) :1501-1506
[7]  
EPLER GR, 1992, CHEST, V102, pS2, DOI 10.1378/chest.102.1.2S
[8]   DIAGNOSIS OF DRUG ALLERGY IN VITRO WITH LYMPHOCYTE TRANSFORMATION TEST [J].
HALPERN, B ;
KY, NT ;
AMACHE, N .
JOURNAL OF ALLERGY, 1967, 40 (03) :168-&
[9]   IDIOPATHIC PULMONARY FIBROSIS AND HEPATITIS-C VIRUS-INFECTION [J].
IRVING, WL ;
DAY, S ;
JOHNSTON, IDA .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 148 (06) :1683-1684
[10]  
*JAP WELF MIN, 1994, REP DRUG SID EFF